CVS Health promises double-digit earnings growth by 2022 as it tries to allay investor worries over Aetna deal

CVS Health tried to allay investor concerns Tuesday over its $70 billion acquisition of health insurer Aetna last year, projecting double-digit growth after the two companies are fully integrated in a few years.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.